Coping with COVID-19 in Sub-Saharan Africa: What Might the Future Hold?
作者信息
Mennechet Franck J D, Dzomo Guy R Takoudjou
机构信息
Institute of Molecular Genetic of Montpellier, CNRS, University of Montpellier, Montpellier, 34090, France.
University Hospital Complex the "Bon Samaritain", N'Djamena, BP 456, Republic of Chad.
出版信息
Virol Sin. 2020 Dec;35(6):875-884. doi: 10.1007/s12250-020-00279-2. Epub 2020 Sep 1.
Abstract
摘要
相似文献
1
Coping with COVID-19 in Sub-Saharan Africa: What Might the Future Hold?
Virol Sin. 2020 Dec;35(6):875-884. doi: 10.1007/s12250-020-00279-2. Epub 2020 Sep 1.
2
Will COVID-19 be a litmus test for post-Ebola sub-Saharan Africa?
J Med Virol. 2020 Sep;92(9):1373-1375. doi: 10.1002/jmv.25780. Epub 2020 Mar 30.
3
Issues facing TB control (6). Tuberculosis control in sub-Saharan Africa in the face of HIV and AIDS.
Scott Med J. 2000 Oct;45(5 Suppl):47-50; discussion 51. doi: 10.1177/00369330000450S122.
4
COVID-19 preparedness: capacity to manufacture vaccines, therapeutics and diagnostics in sub-Saharan Africa.
Global Health. 2021 Mar 3;17(1):24. doi: 10.1186/s12992-021-00668-6.
5
Importance of Community-Level Interventions During the COVID-19 Pandemic: Lessons from Sub-Saharan Africa.
Am J Trop Med Hyg. 2021 Aug 9;105(4):879-883. doi: 10.4269/ajtmh.20-1533.
6
The regarding the call to explore the unexpected low severity of COVID-19 in Sub-Saharan Africa.
Acta Biomed. 2020 Nov 10;91(4):e2020151. doi: 10.23750/abm.v91i4.10718.
7
Effect of the COVID-19 pandemic on viral hepatitis services in sub-Saharan Africa.
Lancet Gastroenterol Hepatol. 2020 Nov;5(11):966-967. doi: 10.1016/S2468-1253(20)30305-8. Epub 2020 Sep 18.
8
Lockdowns aimed at fighting COVID-19 causing more harm than good in sub-Saharan Africa.
Pan Afr Med J. 2021 Jun 3;39:102. doi: 10.11604/pamj.2021.39.102.26023. eCollection 2021.
9
COVID-19 changing pandemic pattern: why sub-Sahara Africa should reassess the current response approach.
Pan Afr Med J. 2020 Jul 14;35(Suppl 2):111. doi: 10.11604/pamj.supp.2020.35.2.24921. eCollection 2020.
10
Capacity building for infectious disease control in Sub-Saharan Africa.
Pathog Glob Health. 2024 Sep;118(6):526-528. doi: 10.1080/20477724.2023.2272363. Epub 2023 Oct 18.
引用本文的文献
1
High seroprevalence of anti-SARS-CoV-2 antibodies in the capital of Chad.
J Public Health Afr. 2023 Jan 11;13(4):2255. doi: 10.4081/jphia.2022.2255. eCollection 2022 Dec 31.
2
The price of progress: Assessing the financial costs of HIV/AIDS management in East Africa.
Medicine (Baltimore). 2025 May 2;104(18):e42300. doi: 10.1097/MD.0000000000042300.
3
Coping strategies of COVID-19 recovered patients at the Ghana Infectious Disease Centre.
PLoS One. 2025 Jan 8;20(1):e0310921. doi: 10.1371/journal.pone.0310921. eCollection 2025.
4
Narrative Review Explaining the Role of , , and Molecules in COVID-19 Disease in and around Africa.
Infect Dis Rep. 2024 Apr 18;16(2):380-406. doi: 10.3390/idr16020029.
5
A Qualitative Evaluation of COVID-19 Preventative Response Activities in South Kivu, Democratic Republic of the Congo.
Int J Environ Res Public Health. 2022 Oct 17;19(20):13424. doi: 10.3390/ijerph192013424.
6
Educational level, gender and health practices regarding COVID-19 in N'Djamena, Chad: A cross-sectional study.
J Public Health Afr. 2022 May 24;13(1):1948. doi: 10.4081/jphia.2022.1948.
7
Household water access and COVID-19 in Karoi town, Zimbabwe.
Sci Afr. 2022 Jul;16:e01145. doi: 10.1016/j.sciaf.2022.e01145. Epub 2022 Mar 8.
8
Is social media, as a main source of information on COVID-19, associated with perceived effectiveness of face mask use? Findings from six sub-Saharan African countries.
Glob Health Promot. 2022 Sep;29(3):86-96. doi: 10.1177/17579759211065489. Epub 2022 Jan 27.
9
Pneumonia amidst the COVID-19 pandemic in Africa: Challenges and possible solutions.
Health Sci Rep. 2022 Jan 10;5(1):e493. doi: 10.1002/hsr2.493. eCollection 2022 Mar.
10
Coping strategies adapted by Ghanaians during the COVID-19 crisis and lockdown: A population-based study.
PLoS One. 2021 Jun 28;16(6):e0253800. doi: 10.1371/journal.pone.0253800. eCollection 2021.
本文引用的文献
1
Technical guidance for laboratory testing of 2019-nCoV infection (Third Edition).
Biosaf Health. 2020 Mar;2(1):3-5. doi: 10.1016/j.bsheal.2020.02.001. Epub 2020 Feb 5.
2
COVID-19: Avoiding a second tragedy in a tuberculosis burdened country.
Monaldi Arch Chest Dis. 2020 May 21;90(2). doi: 10.4081/monaldi.2020.1338.
3
COVID-19 from the perspective of an immunologist.
Cas Lek Cesk. 2020 Spring;159(2):67-71.
4
COVID-19 in Africa: care and protection for frontline healthcare workers.
Global Health. 2020 May 15;16(1):46. doi: 10.1186/s12992-020-00574-3.
5
Respiratory virus shedding in exhaled breath and efficacy of face masks.
Nat Med. 2020 May;26(5):676-680. doi: 10.1038/s41591-020-0843-2. Epub 2020 Apr 3.
6
The ACE-2 in COVID-19: Foe or Friend?
Horm Metab Res. 2020 May;52(5):257-263. doi: 10.1055/a-1155-0501. Epub 2020 Apr 27.
7
Novel coronavirus disease (COVID-19) in children.
Turk J Med Sci. 2020 Apr 21;50(SI-1):592-603. doi: 10.3906/sag-2004-174.
8
The Burden of COVID-19 in People Living with HIV: A Syndemic Perspective.
AIDS Behav. 2020 Aug;24(8):2244-2249. doi: 10.1007/s10461-020-02871-9.
9
Tuberculosis and HIV responses threatened by COVID-19.
Lancet HIV. 2020 May;7(5):e319-e320. doi: 10.1016/S2352-3018(20)30109-0. Epub 2020 Apr 8.
10
The COVID-19 vaccine development landscape.
Nat Rev Drug Discov. 2020 May;19(5):305-306. doi: 10.1038/d41573-020-00073-5.
Zotero 插件